Neem's Hill AB (STO:NEEMS.B)

Market Cap	78.91M +22.9%
Revenue (ttm)	12.16M +22.4%
Net Income	-7.99M
EPS	n/a
Shares Out	25.45M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	48,559
Open	2.990
Previous Close	3.050
Day's Range	2.900 - 3.280
52-Week Range	2.700 - 7.760
Beta	0.96
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 11, 2026

About Neem's Hill AB

Neem's Hill AB, a medical technology company, engages in the development of patented treatment alternatives for humans and animals with cancer in Sweden and internationally. It offers IQwave, an electroporation that generates tumor-specific electrical stimulation for the treatment of solid superficial tumors of various sizes and locations. Neem's Hill AB was formerly known as Scandinavian ChemoTech AB (publ) and changed its name to Neem's Hill AB in July 2026. The company was incorporated in 2013 and is headquartered in Lund, Sweden.

• Industry: Electromedical and Electrotherapeutic Apparatus
• Founded: 2013
• Employees: 1
• Stock Exchange: Nasdaq Stockholm
• Ticker Symbol: NEEMS.B

Financial Performance

In 2025, Neem's Hill AB's revenue was 12.29 million, an increase of 87.10% compared to the previous year's 6.57 million. Losses were -8.06 million, -41.27% less than in 2024.

Data Source: S&P Global Market Intelligence

Fundamental and historical data is provided by S&P Global Market Intelligence.

Last checked:

Aug 13, 2026

Data Sources Report a data error